ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the transition period from _______________ to ______________ |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Securities registered pursuant to Section 12(b) of the Act: | ||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
☑ | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||
Emerging growth company |
Page No. | ||
Part I: | ||
ITEM 1. Business ................................................................................................................................. | ||
ITEM 1A. Risk Factors ............................................................................................................................ | ||
ITEM 1B. Unresolved Staff Comments ............................................................................................... | ||
ITEM 1C. Cybersecurity ......................................................................................................................... | ||
ITEM 2. Properties ............................................................................................................................... | ||
ITEM 3. Legal Proceedings ................................................................................................................. | ||
ITEM 4. Mine Safety Disclosures ....................................................................................................... | ||
Information about our Executive Officers .............................................................................................. | ||
Part II: | ||
Purchases of Equity Securities ........................................................................................... | ||
ITEM 6. [Reserved] ............................................................................................................................... | ||
Operations ............................................................................................................................. | ||
ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk ........................................ | ||
ITEM 8. Financial Statements and Supplementary Data .............................................................. | ||
Disclosure .............................................................................................................................. | ||
ITEM 9A. Controls and Procedures ..................................................................................................... | ||
ITEM 9B. Other Information ................................................................................................................. | ||
ITEM 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections ....................... | ||
Part III : | ||
ITEM 10. Directors, Executive Officers and Corporate Governance ............................................. | ||
ITEM 11. Executive Compensation ..................................................................................................... | ||
Stockholder Matters ............................................................................................................. | ||
ITEM 14. Principal Accounting Fees and Services ........................................................................... | ||
Part IV: | ||
ITEM 15. Exhibits, Financial Statement Schedules ......................................................................... | ||
ITEM 16. Form 10-K Summary ........................................................................................................... | ||
Signatures ..................................................................................................................................................................... |
ITEM 1. | BUSINESS. |
ITEM 1A. | RISK FACTORS. |
ITEM 1B. | UNRESOLVED STAFF COMMENTS. |
ITEM 1C. | CYBERSECURITY. |
ITEM 2. | PROPERTIES. |
ITEM 3. | LEGAL PROCEEDINGS. |
ITEM 4. | MINE SAFETY DISCLOSURES. |
Name | Age | Position | Held Since | Recent Business Experience |
Kenneth L. Bedingfield | 52 | Chief Financial Officer (“CFO”) and President, AR(1) | December 2023 | CEO, Epirus, Inc. (“Epirus”) (2022-2023); President and Chief Operating Officer, Epirus (2022); CFO, Epirus (2020-2022); CFO, Northrop Grumman Corporation (“Northrop Grumman”) (2015-2020), Aerospace Sector CFO, Northrop Grumman (2013-2015) |
John P. Cantillon | 58 | Vice President (“VP”), Principal Accounting Officer | May 2024 | VP, Assistant Controller (2023-2024); VP of Finance Manufacturing Operations, Pratt & Whitney (2023); VP and Controller, Pratt & Whitney (2020-2023) |
Christoph T. Feddersen | 53 | VP, General Counsel & Secretary | August 2024 | VP, General Counsel of L3Harris SAS (2024); VP and General Counsel, Collins Aerospace Systems (2018-2023) |
Christopher E. Kubasik | 63 | Chair and CEO | June 2022 | Vice Chair and CEO (2021); Vice Chair, President and Chief Operating Officer (2019-2021); Chairman, CEO and President, L3 Technologies, Inc. (“L3”) (2018-2019) |
Samir B. Mehta | 52 | President, CS | January 2023 | President of Advanced Structures, Collins Aerospace (2018-2022); President, Aftermarket (2017-2018) |
Melanie Rakita | 47 | VP and Chief Human Resources Officer | April 2023 | VP, Human Resources for L3Harris IMS (2023), SAS (2019-2023), and Legacy Harris Corporation Electronic Systems (2018-2019) |
Jonathan P. Rambeau | 52 | President, IMS | October 2022 | VP and General Manager, Integrated Warfare Systems and Sensors of the Rotary and Mission Systems business, Lockheed Martin (2020-2022); VP and General Manager, C6ISR, Rotary and Mission Systems, Lockheed Martin (2016-2020) |
Edward J. Zoiss | 60 | President, SAS | June 2019 | President, Legacy Harris Corporation Electronic Systems (2015-2019) |
ITEM 5. | MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. |
Period* | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced plans or programs(1) | Maximum approximate dollar value of shares that may yet be purchased under the plans or programs(1) ($ in millions) | |||
Month No. 1 | |||||||
(September 28, 2024 - November 1, 2024) | |||||||
Repurchase program(1) | — | $— | — | $3,422 | |||
Employee transactions(2) | 2,042 | $243.33 | — | — | |||
Month No. 2 | |||||||
(November 2, 2024 - November 29, 2024) | |||||||
Repurchase program(1) | 60,000 | $227.72 | 60,000 | $3,407 | |||
Employee transactions(2) | 5,294 | $245.69 | — | — | |||
Month No. 3 | |||||||
(November 30, 2024 - January 3, 2025) | |||||||
Repurchase program(1) | 115,000 | $225.10 | 115,000 | $3,381 | |||
Employee transactions(2) | 1,412 | $239.47 | — | — | |||
Total | 183,748 | 175,000 | $3,381 |
ITEM 6. | [RESERVED.] |
ITEM 7. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
Fiscal Year Ended | |||
(Dollars in millions, except per share amounts) | January 3, 2025 | December 29, 2023 | |
Revenue | |||
Products | $15,134 | $13,694 | |
Services | 6,191 | 5,725 | |
Total revenue | 21,325 | 19,419 | |
Cost of revenue | |||
Products | (11,019) | (9,711) | |
Services | (4,782) | (4,595) | |
Cost of revenue | (15,801) | (14,306) | |
Gross margin | 5,524 | 5,113 | |
General and administrative expenses | (3,568) | (3,313) | |
Impairment of goodwill and other assets | (38) | (374) | |
Operating income | 1,918 | 1,426 | |
Non-service FAS pension income and other, net(1) | 354 | 338 | |
Interest expense, net | (675) | (543) | |
Income before income taxes | 1,597 | 1,221 | |
Income taxes | (85) | (23) | |
Effective Tax Rate | 5.3% | 1.9% | |
Net income | 1,512 | 1,198 | |
Noncontrolling interests, net of income taxes | (10) | 29 | |
Net income attributable to L3Harris Technologies, Inc. | $1,502 | $1,227 | |
Diluted EPS(2) | $7.87 | $6.44 |
Fiscal Year Ended | |||
(In millions) | January 3, 2025 | December 29, 2023 | |
SAS | $4,788 | $4,879 | |
IMS | 4,270 | 4,006 | |
CS | 4,498 | 4,057 | |
AR | 1,578 | 752 | |
Total products revenue | $15,134 | $13,694 |
Fiscal Year Ended | |||
(In millions) | January 3, 2025 | December 29, 2023 | |
SAS | $2,029 | $1,928 | |
IMS | 2,501 | 2,537 | |
CS | 892 | 960 | |
AR | 769 | 300 | |
Total services revenue | $6,191 | $5,725 |
Fiscal Year Ended | |||
(In millions) | January 3, 2025 | December 29, 2023 | |
SAS | $(3,763) | $(3,777) | |
IMS | (3,269) | (3,055) | |
CS | (2,738) | (2,319) | |
AR | (1,199) | (558) | |
Corporate | (50) | (2) | |
Total cost of products revenue | $(11,019) | $(9,711) |
Fiscal Year Ended | |||
(In millions) | January 3, 2025 | December 29, 2023 | |
SAS | $(1,615) | $(1,554) | |
IMS | (1,897) | (1,944) | |
CS | (682) | (845) | |
AR | (603) | (259) | |
Corporate | 15 | 7 | |
Total cost of services revenue | $(4,782) | $(4,595) |
Fiscal Year Ended | |||
(In millions) | January 3, 2025 | December 29, 2023 | |
Amortization of acquisition-related intangibles | $(779) | $(687) | |
LHX NeXt implementation costs(1) | (267) | (115) | |
Merger, acquisition, and divestiture-related expenses | (102) | (174) | |
Business divestiture-related losses, net(2) | (19) | (51) | |
Company-funded R&D costs | (515) | (480) | |
Selling and marketing | (445) | (450) | |
Other G&A expenses(3) | (1,441) | (1,356) | |
G&A expenses | $(3,568) | $(3,313) |
Fiscal Year Ended | |||
(In millions) | January 3, 2025 | December 29, 2023 | |
Non-service FAS pension income(1) | $322 | $310 | |
Other, net(2) | 32 | 28 | |
Non-service FAS pension income and other, net | $354 | $338 |
Fiscal Year Ended | |||||
(Dollars in millions) | January 3, 2025 | December 29, 2023 | % Inc/(Dec) | ||
Revenue | $6,869 | $6,856 | —% | ||
Operating income | 812 | 756 | 7% | ||
Operating margin | 11.8% | 11.0% |
Fiscal Year Ended | |||||
(Dollars in millions) | January 3, 2025 | December 29, 2023 | % Inc/(Dec) | ||
Revenue | $6,842 | $6,630 | 3% | ||
Operating income | 838 | 459 | 83% | ||
Operating margin | 12.2% | 6.9% |
Fiscal Year Ended | |||||
(Dollars in millions) | January 3, 2025 | December 29, 2023 | % Inc/(Dec) | ||
Revenue | $5,459 | $5,070 | 8% | ||
Operating income | 1,324 | 1,229 | 8% | ||
Operating margin | 24.3% | 24.2% |
Fiscal Year Ended | |||||
(Dollars in millions) | January 3, 2025 | December 29, 2023 | % Inc/(Dec) | ||
Revenue | $2,347 | $1,052 | 123% | ||
Operating income | 294 | 122 | 141% | ||
Operating margin | 12.5% | 11.6% |
Fiscal Year Ended | |||
(Dollars in millions) | January 3, 2025 | December 29, 2023 | |
Unallocated corporate department expense(1) | (123) | (62) | |
Amortization of acquisition-related intangibles(2) | (853) | (779) | |
Additional cost of revenue related to the fair value step-up in inventory sold | — | (30) | |
Merger, acquisition, and divestiture-related expenses | (102) | (174) | |
Business divestiture-related losses, net(3) | (19) | (51) | |
Impairment of goodwill and other assets(4) | (14) | (39) | |
LHX NeXt implementation costs(5) | (267) | (115) | |
FAS/CAS operating adjustment(6) | 28 | 110 | |
Total unallocated corporate expense | $(1,350) | $(1,140) |
Fiscal Year Ended | |||
(In millions) | January 3, 2025 | December 29, 2023 | |
Cash and cash equivalents, beginning of period | $560 | $880 | |
Operating Activities: | |||
Net income | 1,512 | 1,198 | |
Non-cash adjustments | 1,576 | 1,162 | |
Changes in working capital | 66 | 286 | |
Other, net | (595) | (550) | |
Net cash provided by operating activities | $2,559 | $2,096 | |
Net cash used in investing activities | (263) | (7,021) | |
Net cash (used in) provided by financing activities | (2,224) | 4,594 | |
Effect of exchange rate changes on cash and cash equivalents | (17) | 11 | |
Net increase (decrease) in cash and cash equivalents | $55 | $(320) | |
Cash and cash equivalents, end of period | $615 | $560 |
January 3, 2025 | December 29, 2023 | ||||||
Pension | Other Benefits | Pension | Other Benefits | ||||
Discount rate | 5.46% | 5.38% | 4.91% | 4.87% |
Fiscal Year Ended | |||||||
January 3, 2025 | December 29, 2023 | ||||||
Pension | Other Benefits | Pension | Other Benefits | ||||
Discount rate to determine service cost | 4.92% | 5.00% | 5.18% | 5.26% | |||
Discount rate to determine interest cost | 4.80% | 4.78% | 5.08% | 5.06% | |||
Expected return on plan assets | 7.45% | 7.50% | 7.46% | 7.50% |
(In millions) | 25 Basis Point Increase | 25 Basis Point Decrease | |
PBO | $(155) | $161 | |
Net periodic benefit income | $7 | $(8) |
(In millions) | 25 Basis Point Increase | 25 Basis Point Decrease | |
Net periodic benefit income | $(20) | $20 |
ITEM 7A. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. |
Cost estimation for revenue recognition on development and production contracts | |
Description of the Matter | As described in the consolidated financial statements, the Company recognized revenue for certain of its development and production contracts over time, typically using a percentage of completion cost-to-cost method, which required estimates of costs at completion for each contract. At the outset of each contract, the Company gauges its complexity and perceived risks and establishes an estimated total cost at completion with these expectations. After establishing the estimated total cost at completion, the Company reviews the progress and performance on its ongoing contracts at least quarterly and updates the estimated total cost at completion. Such estimates are subject to change during the performance of the contract and significant changes in estimates could have a material effect on the Company’s results of operations. Auditing the cost estimation for revenue recognition on development and production contracts where revenue is recognized over time using the percentage of completion cost- to-cost method involved subjective auditor judgment because the Company’s development of the estimated total cost at completion requires estimates of the cost of the work to be completed based on the Company’s underlying assumptions around achieving the technical, schedule and cost aspects of its contracts. In determining the estimates of the cost of the work to be completed, the Company considered the nature and complexity of the work to be performed, subcontractor performance and the risk and impact of delayed performance. Estimates of total cost at completion are also affected by management’s assessment of the current status of the contract and expectation for performance on the contract, as well as historical experience. |
How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s accounting for cost estimation for development and production contracts. For example, we tested certain controls over management’s review of the estimate at completion analyses and the significant assumptions underlying the estimated total costs at completion. We also tested certain of management’s controls to validate that the data used in the estimate at completion analyses was complete and accurate. To test the cost estimation for development and production contracts, our audit procedures included, among others, obtaining an understanding of the contract, meeting with program management to confirm our understanding of the risks associated with the arrangement and the current contract performance, review of customer correspondence and contractual milestones and comparing cost estimates to historical cost experience with similar contracts, when applicable. Additionally, we obtained an understanding of the Company’s past performance of estimating total costs at completion by reviewing changes in the cost estimates from previous periods and reviewing the overall accuracy of management’s cost to completion estimations through lookback analyses. |
Valuation of Goodwill | |
Description of the Matter | At January 3, 2025, the Company’s goodwill was $20.3 billion. As more fully described in the consolidated financial statements, the Company tests goodwill for impairment annually (or under certain circumstances, more frequently) at the reporting unit level using either a qualitative or quantitative assessment. Under the quantitative assessment to test for goodwill impairment, the Company compares the fair value of a reporting unit to its carrying amount, including goodwill. The Company estimates the fair value of its reporting units using a combination of a discounted cash flows analysis and market-based valuation methodologies. Auditing the Company’s quantitative goodwill impairment tests involved subjective auditor judgment due to the significant estimation required in management’s determination of the fair value of the reporting units. The significant estimation is primarily due to the sensitivity of the respective fair values to underlying assumptions, particularly at the Aerojet Rocketdyne (AR) reporting unit, including changes in the weighted average cost of capital and projected EBITDA margins. These assumptions relate to the expected future operating performance of the Company’s AR reporting unit, are forward-looking, and are sensitive to and affected by economic, industry and company-specific qualitative factors. |
How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of relevant internal controls over the Company’s goodwill impairment review process, including controls over management’s review of the significant assumptions used in the valuation models. We also tested management’s controls to validate that the data used in the valuation models was complete and accurate. To test the estimated fair value of the Company’s AR reporting unit, we performed audit procedures that included, among others, assessing the valuation methodologies used by the Company, involving our valuation specialists to assist in testing the significant assumptions discussed above, and testing the completeness and accuracy of the underlying data the Company used in its valuation analyses. For example, we compared the significant assumptions used by management to current industry, market and economic trends, the historical results of the AR reporting unit and other relevant factors. We also assessed the historical accuracy of management’s valuation estimates and performed sensitivity analyses of significant assumptions used in the impairment tests to evaluate the change in the fair value of the AR reporting unit resulting from changes in the significant assumptions. In addition, we reviewed the reconciliation of the fair value of the reporting units based on the annual impairment test to the market capitalization of the Company. |
Fiscal Year Ended | |||||
(In millions, except per share amounts) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Revenue | |||||
Products | $ | $ | $ | ||
Services | |||||
Total revenue | |||||
Cost of revenue | |||||
Products | ( | ( | ( | ||
Services | ( | ( | ( | ||
Total cost of revenue | ( | ( | ( | ||
General and administrative expenses | ( | ( | ( | ||
Impairment of goodwill and other assets | ( | ( | ( | ||
Operating income | |||||
Non-service FAS pension income and other, net | |||||
Interest expense, net | ( | ( | ( | ||
Income before income taxes | |||||
Income taxes | ( | ( | ( | ||
Net income | |||||
Noncontrolling interests, net of income taxes | ( | ||||
Net income attributable to L3Harris Technologies, Inc. | $ | $ | $ | ||
Net income per common share attributable to L3Harris Technologies, Inc. common shareholders | |||||
Basic | $ | $ | $ | ||
Diluted | $ | $ | $ |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Net income | $ | $ | $ | ||
Other comprehensive income (loss): | |||||
Foreign currency translation, net of income taxes | ( | ( | |||
Hedging derivatives, net of income taxes | ( | ( | |||
Pension and other postretirement benefits, net of income taxes | ( | ||||
Other comprehensive income (loss) recognized during the period | ( | ||||
Reclassification adjustments for (gains) losses included in net income | ( | ( | |||
Other comprehensive income (loss), net of income taxes | ( | ||||
Total comprehensive income | |||||
Comprehensive (income) loss attributable to noncontrolling interest | ( | ||||
Total comprehensive income attributable to L3Harris Technologies, Inc. | $ | $ | $ |
(In millions, except shares) | January 3, 2025 | December 29, 2023 | |
Assets | |||
Current assets | |||
Cash and cash equivalents | $ | $ | |
Receivables, net | |||
Contract assets | |||
Inventories, net | |||
Income taxes receivable | |||
Other current assets | |||
Assets of business held for sale | |||
Total current assets | |||
Non-current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangible assets, net | |||
Deferred income taxes | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities and equity | |||
Current liabilities | |||
Short-term debt | $ | $ | |
Current portion of long-term debt, net | |||
Accounts payable | |||
Contract liabilities | |||
Compensation and benefits | |||
Other current liabilities | |||
Income taxes payable | |||
Liabilities of business held for sale | |||
Total current liabilities | |||
Non-current liabilities | |||
Long-term debt, net | |||
Deferred income taxes | |||
Other long-term liabilities | |||
Total liabilities | |||
Equity | |||
Shareholders’ Equity: | |||
Preferred stock, without par value; | |||
Common stock, $ outstanding December 29, 2023, respectively | |||
Paid-in capital | |||
Retained earnings | |||
Accumulated other comprehensive income (loss) | ( | ||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Operating Activities | |||||
Net income | $ | $ | $ | ||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||
Depreciation and amortization | |||||
Share-based compensation | |||||
Net periodic benefit income | ( | ( | ( | ||
Share-based matching contributions under defined contribution plans | |||||
Impairment of goodwill and other assets | |||||
Deferred income taxes | ( | ( | |||
(Increase) decrease in: | |||||
Receivables, net | ( | ||||
Contract assets | ( | ||||
Inventories, net | ( | ( | |||
Other current assets | ( | ( | |||
Increase (decrease) in: | |||||
Accounts payable | ( | ||||
Contract liabilities | |||||
Compensation and benefits | ( | ( | |||
Other current liabilities | ( | ( | |||
Income taxes | ( | ( | |||
Other operating activities | ( | ( | ( | ||
Net cash provided by operating activities | |||||
Investing Activities | |||||
Net cash paid for acquired businesses | ( | ||||
Capital expenditures | ( | ( | ( | ||
Proceeds from sale of property, plant and equipment, net | |||||
Proceeds from sales of businesses | |||||
Other investing activities | ( | ( | ( | ||
Net cash used in investing activities | ( | ( | ( | ||
Financing Activities | |||||
Proceeds from issuances of long-term debt, net | |||||
Repayments of long-term debt | ( | ( | ( | ||
Change in commercial paper, maturities under 90 days, net | ( | ||||
Proceeds from commercial paper, maturities over 90 days | |||||
Repayments of commercial paper, maturities over 90 days | ( | ( | |||
Proceeds from exercises of employee stock options | |||||
Repurchases of common stock | ( | ( | ( | ||
Dividends paid | ( | ( | ( | ||
Other financing activities | ( | ( | ( | ||
Net cash (used in) provided by financing activities | ( | ( | |||
Effect of exchange rate changes on cash and cash equivalents | ( | ( | |||
Net increase (decrease) in cash and cash equivalents | ( | ( | |||
Cash and cash equivalents, beginning of period | |||||
Cash and cash equivalents, end of period | $ | $ | $ |
Fiscal Year Ended | |||||
(In millions, except per share amounts) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Common Stock | |||||
Beginning balance | $ | $ | $ | ||
Shares issued under stock incentive plans | |||||
Shares issued under defined contribution plans | |||||
Repurchases and retirement of common stock | ( | ( | ( | ||
Ending balance | |||||
Paid-in Capital | |||||
Beginning balance | |||||
Shares issued under stock incentive plans | |||||
Shares issued under defined contribution plans | |||||
Share-based compensation expense | |||||
Tax withholding payments on share-based awards | ( | ( | ( | ||
Repurchases and retirement of common stock | ( | ( | ( | ||
Other | ( | ( | |||
Ending balance | |||||
Retained Earnings | |||||
Beginning balance | |||||
Net income attributable to L3Harris Technologies, Inc. | |||||
Repurchases and retirement of common stock | ( | ( | ( | ||
Cash dividends | ( | ( | ( | ||
Other | ( | ( | |||
Ending balance | |||||
Accumulated Other Comprehensive Income (Loss) | |||||
Beginning balance | ( | ( | ( | ||
Other comprehensive income (loss), net of income taxes | ( | ||||
Ending balance | ( | ( | |||
Noncontrolling Interests | |||||
Beginning balance | |||||
Net income (loss) attributable to noncontrolling interests | ( | ( | |||
Other | ( | ( | ( | ||
Ending balance | |||||
Total Equity | $ | $ | $ | ||
Cash dividends per share | $ | $ | $ |
Fiscal Year Ended | |||||
(In millions, except per share amounts) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Net EAC adjustments, before income taxes | $ | $( | $ | ||
Net EAC adjustments, net of income taxes | ( | ||||
Net EAC adjustments, net of income taxes, per diluted share | ( |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
FAS pension service cost | $( | $( | $( | ||
Less: CAS pension cost | ( | ( | ( | ||
FAS/CAS operating adjustment |
Fiscal Year Ended | |||||
(In millions, except per share amounts) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Basic weighted-average common shares outstanding | |||||
Impact of dilutive share-based awards | |||||
Diluted weighted-average common shares outstanding |
(In millions) | January 3, 2025 | December 29, 2023 | |
Contract assets | $ | $ | |
Contract liabilities, current | ( | ( | |
Contract liabilities, non-current(1) | ( | ( | |
Net contract assets | $ | $ |
(In millions) | January 3, 2025 | December 29, 2023 | |
Finished products | $ | $ | |
Work in process | |||
Materials and supplies | |||
Inventories, net | $ | $ |
(In millions) | January 3, 2025 | December 29, 2023 | |
Land | $ | $ | |
Software capitalized for internal use | |||
Buildings | |||
Machinery and equipment | |||
Less: accumulated depreciation and amortization | ( | ( | |
Property, plant and equipment, net | $ | $ |
(In millions) | SAS | IMS | CS | AR | Total | ||||
Balance at December 30, 2022 | $ | $ | $ | ** | $ | ||||
Reallocation of goodwill in business realignment | ( | ||||||||
Goodwill increase from acquisitions(1) | |||||||||
Goodwill decrease from divestitures | ( | — | ( | ||||||
Assets of business held for sale | — | ( | ( | ||||||
Impairment of goodwill | ( | ( | |||||||
Currency translation adjustments | |||||||||
Balance at December 29, 2023 | |||||||||
Goodwill from AJRD acquisition | — | — | — | ||||||
Goodwill decrease from divestitures(2) | ( | ( | ( | ||||||
Impairment of goodwill | ( | ( | |||||||
Currency translation adjustments | ( | ( | ( | ( | |||||
Balance at January 3, 2025 | $ | $ | $ | $ | $ |
January 3, 2025 | December 29, 2023 | ||||||||||
(In millions) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||
Customer relationships | $ | $( | $ | $ | $( | $ | |||||
Developed technologies | ( | ( | |||||||||
Trade names | ( | ( | |||||||||
Other, including contract backlog | ( | ( | |||||||||
Total finite-lived intangible assets | ( | ( | |||||||||
Trade name — indefinite-lived | — | — | |||||||||
Total intangible assets, net | $ | $( | $ | $ | $( | $ |
(In millions) | |
2025 | $ |
2026 | |
2027 | |
2028 | |
2029 | |
Thereafter | |
Total | $ |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Current: | |||||
United States | $( | $ | $ | ||
International | |||||
State and local | |||||
Total current income taxes | ( | ||||
Deferred: | |||||
United States | ( | ( | |||
International | ( | ( | |||
State and local | ( | ( | ( | ||
Total deferred income taxes | ( | ( | |||
Total income taxes | $ | $ | $ |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
U.S. statutory income tax rate | |||||
State taxes | |||||
International income | |||||
Non-deductible goodwill impairment | |||||
R&D tax credit | ( | ( | ( | ||
FDII deduction | ( | ( | ( | ||
Changes in valuation allowance | ( | ||||
Impact of divestitures and reorganizations | ( | ( | |||
Share-based compensation(1) | ( | ( | |||
Settlement of tax audits | ( | ( | ( | ||
Other items | ( | ( | |||
Effective income tax rate |
(In millions) | January 3, 2025 | December 29, 2023 | |
Deferred tax assets, net: | |||
Accruals | $ | $ | |
Tax loss and credit carryforwards(1) | |||
Operating lease obligation | |||
Capitalized research and experimental expenditures | |||
Other | |||
Valuation allowance(2) | ( | ( | |
Deferred tax assets, net | |||
Deferred tax liabilities: | |||
Property, plant and equipment | ( | ( | |
Acquired intangibles | ( | ( | |
Operating lease ROU asset | ( | ( | |
Deferred revenue on long-term contracts(3) | ( | ||
Other | ( | ( | |
Deferred tax liabilities | ( | ( | |
Net deferred tax liabilities | $( | $( |
(In millions) | January 3, 2025 | December 29, 2023 | |
Deferred income tax assets | $ | $ | |
Deferred income tax liabilities | ( | ( | |
Net deferred tax liabilities | $( | $( |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Balance at beginning of fiscal year | $ | $ | $ | ||
Additions based on tax positions taken during current period | |||||
Additions based on tax positions taken during prior period | |||||
Additions from tax positions related to acquired entities | |||||
Decreases based on tax positions taken during prior period | ( | ( | ( | ||
Decreases from lapse in statutes of limitations | ( | ( | ( | ||
Decreases from settlements | ( | ( | ( | ||
Balance at end of fiscal year(1) | $ | $ | $ |
(In millions) | January 3, 2025 | December 29, 2023 | |
Variable-rate debt: | |||
Term Loan 2025 | $ | $ | |
Fixed-rate debt:(1) | |||
Total variable and fixed-rate debt | |||
Financing lease obligations and other debt | |||
Long-term debt, including the current portion of long-term debt | |||
Plus: unamortized bond premium | |||
Less: unamortized discounts and issuance costs | ( | ( | |
Long-term debt, including the current portion of long-term debt, net | |||
Less: current portion of long-term debt, net | ( | ( | |
Total long-term debt, net | $ | $ |
January 3, 2025 | December 29, 2023 | ||||||
(In millions) | Carrying Amount | Fair Value | Carrying Amount | Fair Value | |||
Term Loan 2025(1) | $ | $ | $ | $ | |||
All other long-term debt, net (including current portion)(2) | |||||||
Long-term debt, including the current portion of long-term debt, net | $ | $ | $ | $ |
January 3, 2025 | December 29, 2023 | ||||||
(In millions) | Total | Level 1 | Total | Level 1 | |||
Assets | |||||||
Deferred compensation plan assets:(1) | |||||||
Equity and fixed income securities | $ | $ | $ | $ | |||
Investments measured at NAV: | |||||||
Corporate-owned life insurance | |||||||
Total fair value of deferred compensation plan assets | $ | $ | |||||
Liabilities | |||||||
Deferred compensation plan liabilities:(2) | |||||||
Equity securities and mutual funds | $ | $ | $ | $ | |||
Investments measured at NAV: | |||||||
Common/collective trusts and guaranteed investment contracts | |||||||
Total fair value of deferred compensation plan liabilities | $ | $ |
January 3, 2025 | December 29, 2023 | ||||||||||
(In millions) | Pension | Other Benefits | Total | Pension | Other Benefits | Total | |||||
Change in benefit obligation | |||||||||||
PBO at beginning of fiscal year | $ | $ | $ | $ | $ | $ | |||||
Service cost | |||||||||||
Interest cost | |||||||||||
Actuarial (gain) loss | ( | ( | ( | ( | |||||||
Benefits paid(1) | ( | ( | ( | ( | ( | ( | |||||
Expenses paid | ( | ( | ( | ( | |||||||
Currency translation adjustment | ( | ( | ( | ||||||||
Acquisitions(2) | |||||||||||
Other | ( | ( | ( | ||||||||
PBO at end of fiscal year | $ | $ | $ | $ | $ | $ | |||||
Change in plan assets | |||||||||||
Plan assets at beginning of fiscal year | $ | $ | $ | $ | $ | $ | |||||
Actual return on plan assets | |||||||||||
Employer contributions | |||||||||||
Benefits paid(1) | ( | ( | ( | ( | ( | ( | |||||
Expenses paid | ( | ( | ( | ( | |||||||
Currency translation adjustment | ( | ( | |||||||||
Acquisitions(2) | |||||||||||
Other | |||||||||||
Plan assets at end of fiscal year | $ | $ | $ | $ | $ | $ | |||||
Funded status at end of fiscal year | $ | $ | $ | $ | $ | $ |
January 3, 2025 | December 29, 2023 | ||||||||||
(In millions) | Pension | Other Benefits | Total | Pension | Other Benefits | Total | |||||
Assets of business held for sale | $ | $ | $ | $ | $ | $ | |||||
Other non-current assets | |||||||||||
Compensation and benefits | ( | ( | ( | ( | ( | ( | |||||
Other long-term liabilities | ( | ( | ( | ( | ( | ( |
January 3, 2025 | December 29, 2023 | ||||||||||
(In millions) | Pension | Other Benefits | Total | Pension | Other Benefits | Total | |||||
Actuarial (gain) loss | $( | $( | $( | $ | $( | $ | |||||
Net prior service (credit) cost | ( | ( | ( | ( | |||||||
Total recognized in accumulated other comprehensive income (loss), pre-tax | $( | $( | $( | $ | $( | $( |
January 3, 2025 | December 29, 2023 | ||||||
(In millions) | Pension | Other Benefits | Pension | Other Benefits | |||
PBO | |||||||
Fair value of plan assets |
January 3, 2025 | December 29, 2023 | ||||||
(In millions) | Pension | Other Benefits | Pension | Other Benefits | |||
ABO | $ | N/A | $ | N/A | |||
Fair value of plan assets | N/A | N/A |
Fiscal Year Ended | |||||||||||
January 3, 2025 | December 29, 2023 | December 30, 2022 | |||||||||
(In millions) | Pension | Other Benefits | Pension | Other Benefits | T o t a l | Pension | Other Benefits | ||||
Net periodic benefit income | |||||||||||
Operating | |||||||||||
Service cost | $ | $ | $ | $ | $ | $ | |||||
Non-operating | |||||||||||
Interest cost | |||||||||||
Expected return on plan assets | ( | ( | ( | ( | ( | ( | |||||
Amortization of net actuarial (gain) loss | ( | ( | ( | ( | ( | ||||||
Amortization of prior service (credit) cost | ( | ( | ( | ||||||||
Non-service cost periodic benefit income | ( | ( | ( | ( | ( | ( | |||||
Net periodic benefit income | $( | $( | $( | $( | $( | $( | |||||
Other changes in plan assets and benefit obligations recognized in other comprehensive income | |||||||||||
Net actuarial (gain) loss | $( | $( | $( | $( | $ | $( | |||||
Prior service (credit) cost | ( | ||||||||||
Amortization of net actuarial gain (loss) | ( | ||||||||||
Amortization of prior service credit (cost) | ( | ( | ( | ||||||||
Currency translation adjustment | |||||||||||
Total change recognized in other comprehensive income | ( | ( | ( | ||||||||
Total impact from net periodic benefit income and changes in other comprehensive income | $( | $( | $( | $( | $( | $( |
January 3, 2025 | December 29, 2023 | ||||||
Pension(1) | Other Benefits | Pension | Other Benefits | ||||
Discount rate | |||||||
Rate of future compensation increase | N/A | N/A | |||||
Cash balance interest crediting rate | N/A | N/A |
Fiscal Year Ended | |||||||||||
January 3, 2025 | December 29, 2023 | December 30, 2022 | |||||||||
Pension(1) | Other Benefits | Pension | Other Benefits | Pension | Other Benefits | ||||||
Discount rate to determine service cost | |||||||||||
Discount rate to determine interest cost | |||||||||||
Expected return on plan assets | |||||||||||
Rate of future compensation increase | N/A | N/A | N/A | ||||||||
Cash balance interest crediting rate | N/A | N/A | N/A |
Target Asset Allocation | |||
Equity investments | — | ||
Fixed income investments | — | ||
Alternative investments | — | ||
Cash and cash equivalents | — |
January 3, 2025 | |||||||
(In millions) | Total | Level 1 | Level 2 | Level 3 | |||
Asset category | |||||||
Equities: | |||||||
Domestic equities | $ | $ | $ | $ | |||
International equities | |||||||
Real estate investment trusts | |||||||
Fixed income: | |||||||
Corporate bonds | |||||||
Government securities | |||||||
Securitized assets | |||||||
Fixed income funds | |||||||
Cash and cash equivalents | |||||||
Other | |||||||
Total | $ | $ | $ | ||||
Investments measured at NAV: | |||||||
Equity funds | |||||||
Fixed income funds | |||||||
Hedge funds | |||||||
Private equity funds | |||||||
Real asset funds | |||||||
Other | |||||||
Total investments measured at NAV | |||||||
Receivables, net | |||||||
Total fair value of plan assets | $ |
December 29, 2023 | |||||||
(In millions) | Total | Level 1 | Level 2 | Level 3 | |||
Asset category | |||||||
Equities: | |||||||
Domestic equities | $ | $ | $ | $ | |||
International equities | |||||||
Real estate investment trusts | |||||||
Fixed income: | |||||||
Corporate bonds | |||||||
Government securities | |||||||
Securitized assets | |||||||
Fixed income funds | |||||||
Cash and cash equivalents | |||||||
Other | |||||||
Total | $ | $ | $ | ||||
Investments measured at NAV: | |||||||
Equity funds | |||||||
Fixed income funds | |||||||
Hedge funds | |||||||
Private equity funds | |||||||
Real asset funds | |||||||
Other | |||||||
Total investments measured at NAV | |||||||
Receivables, net | |||||||
Total fair value of plan assets | $ |
(In millions) | Pension | Other Benefits(1) | Total | ||
Fiscal Years: | |||||
2025 | $ | $ | $ | ||
2026 | |||||
2027 | |||||
2028 | |||||
2029 | |||||
2030 — 2034 |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Share-based compensation expense | $ | $ | $ | ||
Amounts recognized in our Consolidated Statement of Operations include: | |||||
Cost of revenue | $ | $ | $ | ||
General and administrative expenses | |||||
Share-based compensation expense, before income taxes | |||||
Income taxes on share-based compensation expense | ( | ( | ( | ||
Share-based compensation expense, net of income taxes | $ | $ | $ |
(In thousands, except per unit amounts) | Units | Weighted-Average Grant-Date Price Per Unit | |
RSUs outstanding at December 29, 2023 | $ | ||
Granted | $ | ||
Vested | ( | $ | |
Forfeited | ( | $ | |
RSUs outstanding at January 3, 2025 | $ |
(In thousands, except per unit amounts) | Units | Weighted-Average Grant-Date Price Per Unit | |
PSUs outstanding at December 29, 2023 | $ | ||
Granted | $ | ||
Adjustment for achievement of performance measures | $ | ||
Vested | ( | $ | |
Forfeited | ( | $ | |
PSUs outstanding at January 3, 2025 | $ |
Fiscal Year Ended | |||||
January 3, 2025 | December 29, 2023 | December 30, 2022 | |||
Expected dividends | |||||
Expected volatility | |||||
Risk-free interest rates | |||||
Expected term (years) |
Shares (In thousands) | Weighted Average Exercise Price Per Share | Weighted Average Remaining Contractual Term (In years) | Aggregate Intrinsic Value (In millions) | ||||
Stock options outstanding at December 29, 2023 | $ | ||||||
Granted | $ | ||||||
Exercised | ( | $ | |||||
Forfeited or expired | ( | $ | |||||
Stock options outstanding at January 3, 2025 | $ | $ | |||||
Stock options exercisable at January 3, 2025 | $ | $ |
(In thousands, except per share amounts) | Shares | Weighted-Average Grant-Date Fair Value Per Share | |
Unvested stock options at December 29, 2023 | $ | ||
Granted | $ | ||
Vested/forfeited, net | ( | $ | |
Unvested stock options at January 3, 2025 | $ |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Operating lease cost | $ | $ | $ | ||
Short-term and equipment lease cost | |||||
Variable lease cost | |||||
Other, net(1) | |||||
Total lease cost | $ | $ | $ |
(In millions) | January 3, 2025 | December 29, 2023 | |
Operating Leases | |||
Other non-current assets | $ | $ | |
Assets of business held for sale | |||
Total operating lease assets | $ | $ | |
Other current liabilities | $ | $ | |
Other long-term liabilities | |||
Liabilities of business held for sale | |||
Total operating lease liabilities | $ | $800 | $ |
Finance Leases | |||
Property, plant and equipment | $ | $ | |
Accumulated amortization | ( | ( | |
Property, plant and equipment, net | |||
Assets of business held for sale | |||
Total finance lease assets | $ | $ | |
Current portion of long-term debt, net | $ | $ | |
Long-term debt, net | |||
Liabilities of business held for sale | |||
Total finance lease liabilities | $ | $ |
Fiscal Year Ended | |||
(In millions, except lease term and discount rate) | January 3, 2025 | December 29, 2023 | |
Cash paid for amounts included in the measurement of lease liabilities | |||
Net cash provided by operating activities - operating lease payments | $ | $ | |
Assets obtained in exchange for new lease obligations | |||
ROU assets obtained with operating leases | $ | $ | |
Property, plant and equipment obtained with finance leases | |||
Weighted average remaining lease term (in years) | |||
Operating leases | |||
Finance leases | |||
Weighted average discount rate | |||
Operating leases | |||
Finance leases |
(In millions) | Operating Leases | Finance Leases | |
2025 | $ | $ | |
2026 | |||
2027 | |||
2028 | |||
2029 | |||
Thereafter | |||
Total future lease payments required(1) | |||
Less: imputed interest | |||
Total | $ | $ |
(In millions) | Foreign currency translation | Hedging derivatives | Pension and other postretirement benefits(1) | Total AOCI | |||
Balance at December 29, 2023 | $( | $( | $ | $( | |||
Other comprehensive (loss) income, before reclassifications to earnings and income taxes | ( | ( | |||||
Income taxes | ( | ( | |||||
Other comprehensive (loss) income before reclassifications to earnings, net of income taxes | ( | ( | |||||
(Gains) losses reclassified to earnings, before income taxes(2) | ( | ( | ( | ||||
Income taxes | |||||||
(Gains) losses reclassified to earnings, net of income taxes | ( | ( | ( | ||||
Other comprehensive (loss) income, net of income taxes | ( | ( | |||||
Balance at January 3, 2025 | $( | $( | $ | $ | |||
Balance at December 30, 2022 | $( | $( | $ | $( | |||
Other comprehensive income, before reclassifications to earnings and income taxes | |||||||
Income taxes | ( | ( | ( | ||||
Other comprehensive income before reclassifications to earnings, net of income taxes | |||||||
Losses (gains) reclassified to earnings, before income taxes(2) | ( | ( | |||||
Income taxes | ( | ||||||
Losses (gains) reclassified to earnings, net of income taxes | ( | ( | |||||
Other comprehensive income, net of income taxes | |||||||
Balance at December 29, 2023 | $( | $( | $ | $( | |||
Balance at December 31, 2021 | $( | $( | $ | $( | |||
Other comprehensive loss, before reclassifications to earnings and income taxes | ( | ( | ( | ( | |||
Income taxes | |||||||
Other comprehensive loss before reclassifications to earnings, net of income taxes | ( | ( | ( | ( | |||
Losses (gains) reclassified to earnings, before income taxes(2) | ( | ||||||
Income taxes | ( | ( | |||||
Losses (gains) reclassified to earnings, net of income taxes | ( | ||||||
Other comprehensive (loss) income, net of income taxes | ( | ( | ( | ||||
Balance at December 30, 2022 | $( | $( | $ | $( |
(In millions) | January 3, 2023 |
Purchase price | $ |
Estimated net working capital and other adjustments | |
Cash consideration paid | |
Settlement of preexisting relationship(1) | |
Fair value of consideration transferred | $ |
(In millions) | Preliminary as of January 3, 2023 | Measurement Period Adjustments, Net(1),(2) | Final as of December 29, 2023 | ||
Receivables | $ | $— | $ | ||
Contract assets | |||||
Inventories, net | ( | ||||
Other current assets | — | ||||
Property, plant and equipment | ( | ||||
Goodwill | |||||
Other intangible assets | ( | ||||
Deferred income taxes | |||||
Other non-current assets | ( | ||||
Total assets acquired | $ | $ | $ | ||
Accounts payable | $ | $— | $ | ||
Contract liabilities | — | ||||
Compensation and benefits | — | ||||
Other current liabilities | |||||
Other long-term liabilities | |||||
Total liabilities assumed | $ | $ | $ | ||
Net assets acquired | $ | $ | $ |
Total | Useful Lives | ||
(In millions) | (In Years) | ||
Customer relationships: | |||
Backlog | $ | ||
Government programs | |||
Total customer relationships | |||
Developed technology | |||
Total identifiable intangible assets acquired | $ |
Fiscal Year Ended | |||
(In millions) | December 29, 2023 | December 30, 2022 | |
Revenue | $ | $ | |
Income before income taxes |
(In millions) | July 28, 2023 |
Cash consideration paid for AJRD outstanding common stock & equity awards | $ |
AJRD debt settled by L3Harris | |
Cash consideration paid | |
Less cash acquired | ( |
Fair value of consideration transferred | $ |
(In millions) | Preliminary as of July 28, 2023 | Measurement Period Adjustments, Net(1) | Final as of September 27, 2024 | ||
Receivables | $ | $— | $ | ||
Contract assets | ( | ||||
Inventories, net | — | ||||
Other current assets | |||||
Income taxes receivable | |||||
Property, plant and equipment | |||||
Goodwill | |||||
Intangible assets | — | ||||
Other non-current assets | |||||
Total assets acquired | $ | $ | $ | ||
Current portion of long-term debt, net | $ | $— | $ | ||
Accounts payable | — | ||||
Contract liabilities | |||||
Compensation and benefits | |||||
Income taxes payable | ( | ||||
Other current liabilities | |||||
Long-term debt, net | — | ||||
Deferred income taxes | ( | ||||
Other long-term liabilities | |||||
Total liabilities assumed | $ | $ | $ | ||
Fair value of consideration transferred | $ | $ | $ |
Total (in millions) | Useful Lives (in years) | ||
Customer relationships: | |||
Backlog | $ | ||
Government programs | |||
Total customer relationships | |||
Trade names | |||
Total identifiable intangible assets acquired | $ |
(In millions) | January 3, 2025 | December 29, 2023 | |
Receivables, net | $ | $ | |
Contract assets | |||
Inventories, net | |||
Other current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangible assets, net | |||
Other non-current assets | |||
Valuation allowance | ( | ( | |
Total assets held for sale | $ | $ | |
Current portion of long-term debt | $ | $ | |
Accounts payable | |||
Contract liabilities | |||
Compensation and benefits | |||
Other current liabilities | |||
Long-term debt, net | |||
Other long-term liabilities | |||
Total liabilities held for sale | $ | $ |
Fiscal Year Ended January 3, 2025 | ||||||
(In millions) | SAS | IMS | CS | AR | Other(1) | Total |
Revenue | $ | $ | $ | $ | $( | $ |
Cost of Revenue | ( | ( | ( | ( | ( | |
Other Segment Costs(2) | ( | ( | ( | ( | ( | |
Unallocated corporate department expense | ( | |||||
Operating income | $ | $ | $ | $ | $— | $ |
Non-service FAS pension income and other, net | ||||||
Interest expense, net | ( | |||||
Income before income taxes | $ |
Fiscal Year Ended December 29, 2023 | ||||||
(In millions) | SAS | IMS | CS | AR | Other(1) | Total |
Revenue | $ | $ | $ | $ | $( | $ |
Cost of Revenue | ( | ( | ( | ( | ( | |
Other Segment Costs(2) | ( | ( | ( | ( | ( | ( |
Unallocated corporate department expense | ( | |||||
Operating income | $ | $ | $ | $ | $— | $ |
Non-service FAS pension income and other, net | ||||||
Interest expense, net | ( | |||||
Income before income taxes | $ |
Fiscal Year Ended December 30, 2022 | ||||||
(In millions) | SAS | IMS | CS | AR | Other(1) | Total |
Revenue | $ | $ | $ | ** | $( | $ |
Cost of revenue | ( | ( | ( | ** | ( | |
Other Segment Costs(2) | ( | ( | ( | ** | ( | ( |
Unallocated corporate department expense | ( | |||||
Operating income | $ | $ | $ | ** | $— | $ |
Non-service FAS pension income and other, net | ||||||
Interest expense, net | ( | |||||
Income before income taxes | $ |
Fiscal Year Ended | |||||||
January 3, 2025 | |||||||
(In millions) | SAS | IMS | CS | AR | |||
Revenue By Customer Relationship | |||||||
Prime contractor | $ | $ | $ | $ | |||
Subcontractor(1) | |||||||
Intersegment | |||||||
Total segment | $ | $ | $ | $ | |||
Revenue By Contract Type | |||||||
Fixed-price(2) | $ | $ | $ | $ | |||
Cost-reimbursable | |||||||
Intersegment | |||||||
Total segment | $ | $ | $ | $ | |||
Revenue By Geographical Region | |||||||
United States | $ | $ | $ | $ | |||
International | |||||||
Intersegment | |||||||
Total segment | $ | $ | $ | $ |
Fiscal Year Ended | |||||||
December 29, 2023 | |||||||
(In millions) | SAS | IMS | CS | AR | |||
Revenue By Customer Relationship | |||||||
Prime contractor | $ | $ | $ | $ | |||
Subcontractor(1) | |||||||
Intersegment | |||||||
Total segment | $ | $ | $ | $ | |||
Revenue By Contract Type | |||||||
Fixed-price(2) | $ | $ | $ | $ | |||
Cost-reimbursable | |||||||
Intersegment | |||||||
Total segment | $ | $ | $ | $ | |||
Revenue By Geographical Region | |||||||
United States | $ | $ | $ | $ | |||
International | |||||||
Intersegment | |||||||
Total segment | $ | $ | $ | $ |
Fiscal Year Ended | |||||||
December 30, 2022 | |||||||
(In millions) | SAS | IMS | CS | AR | |||
Revenue By Customer Relationship | |||||||
Prime contractor | $ | $ | $ | ** | |||
Subcontractor(1) | ** | ||||||
Intersegment | ** | ||||||
Total segment | $ | $ | $ | $ | |||
Revenue By Contract Type | |||||||
Fixed-price(2) | $ | $ | $ | ** | |||
Cost-reimbursable | ** | ||||||
Intersegment | ** | ||||||
Total segment | $ | $ | $ | $ | |||
Revenue By Geographical Region | |||||||
United States | $ | $ | $ | ** | |||
International | ** | ||||||
Intersegment | ** | ||||||
Total segment | $ | $ | $ | $ |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Geographical Information for Operations | |||||
Revenue from U.S. operations | $ | $ | $ | ||
Revenue from international operations |
Fiscal Year Ended | |||||
(In millions) | January 3, 2025 | December 29, 2023 | December 30, 2022 | ||
Capital Expenditures | |||||
SAS | $ | $ | $ | ||
IMS | |||||
CS | |||||
AR | ** | ||||
Corporate | |||||
Total capital expenditures | $ | $ | $ | ||
Depreciation and Amortization | |||||
SAS | $ | $ | $ | ||
IMS | |||||
CS | |||||
AR | ** | ||||
Corporate | |||||
Total depreciation and amortization | $ | $ | $ | ||
Geographical Information for Operations | |||||
Long-lived assets of U.S. operations | $ | $ | $ | ||
Long-lived assets of international operations |
(In millions) | January 3, 2025 | December 29, 2023 | |
Total Assets | |||
SAS | $ | $ | |
IMS | |||
CS | |||
AR | |||
Corporate(1) | |||
Total Assets | $ | $ |
(In millions) | Commercial Commitment Total | Commitments expiring within 1 Year | |
Surety bonds used for performance | $ | $ | |
Standby letters of credit used for: | |||
Advance payments | |||
Performance | |||
Financial | |||
Warranty | |||
Total standby letters of credit | |||
Total commitments | $ | $ |
ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. |
ITEM 9A. | CONTROLS AND PROCEDURES. |
ITEM 9B. | OTHER INFORMATION. |
Name and title | Date of adoption of 10b5-1 Plan(1) | Scheduled expiration date of 10b5-1 Plan(2) | Aggregate number of shares of common stock to be purchased or sold(3) | |||
Up to expiring in 2027 | ||||||
Up to | ||||||
Up to shares of underlying options expiring in 2028 |
ITEM 9C. | DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. |
ITEM 10. | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. |
ITEM 11. | EXECUTIVE COMPENSATION. |
ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS. |
Plan Category | Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)(2) | Weighted- average exercise price of outstanding options, warrants and rights (b)(2) | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) | |||
Equity compensation plans approved by shareholders(1) | 3,544,971 | $191.09 | 21,172,833 | |||
Equity compensation plans not approved by shareholders | — | — | — | |||
Total | 3,544,971 | 191.09 | 21,172,833 |
ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE. |
ITEM 14. | PRINCIPAL ACCOUNTING FEES AND SERVICES. |
ITEM 15. | EXHIBITS, FINANCIAL STATEMENT SCHEDULES. |
Page | |
Financial Statements | |
The following consolidated financial statements of L3Harris Technologies, Inc. are included in Item 8 of this Report at the page numbers referenced below: | |
and December 30, 2022 .................................................................................................................................... | |
December 29, 2023 and December 30, 2022 .............................................................................................. | |
Consolidated Balance Sheet — January 3, 2025 and December 29, 2023 ................................................... | |
and December 30, 2022 ................................................................................................................................... | |
Consolidated Statement of Equity — Fiscal Years Ended January 3, 2025, December 29, 2023 and December 30, 2022 ........................................................................................................................................... | |
Notes to Consolidated Financial Statements ...................................................................................................... | |
The following report of L3Harris Technologies, Inc.’s independent registered public accounting firm with respect to the above referenced consolidated financial statements and their report on internal controls over financial reporting are included in Item 8 and Item 9A of this Report at the page numbers referenced below: | |
Financial Statements .......................................................................................................................................... | |
Over Financial Reporting .................................................................................................................................... | |
Financial Statement Schedules | |
All schedules are omitted because they are not applicable, the amounts are not significant or the required information is shown in the Consolidated Financial Statements or the Notes thereto. |
ITEM 16. | FORM 10-K SUMMARY. |
L3HARRIS TECHNOLOGIES, INC. | ||||
(Registrant) | ||||
Date: February 14, 2025 | By: | /s/ Christopher E. Kubasik | ||
Christopher E. Kubasik | ||||
Chair and Chief Executive Officer |
Signature | Title | Date | ||||
/s/ CHRISTOPHER E. KUBASIK | Chair and Chief Executive Officer (Principal Executive Officer) | February 14, 2025 | ||||
Christopher E. Kubasik | ||||||
/s/ KENNETH L. BEDINGFIELD | Senior Vice President, Chief Financial Officer and President, Aerojet Rocketdyne (Principal Financial Officer) | February 14, 2025 | ||||
Kenneth L. Bedingfield | ||||||
/s/ JOHN P. CANTILLON | Vice President, Principal Accounting Officer (Principal Accounting Officer) | February 14, 2025 | ||||
John P. Cantillon | ||||||
* | Director | February 14, 2025 | ||||
Sallie B. Bailey | ||||||
* | Director | February 14, 2025 | ||||
Thomas A. Dattilo | ||||||
* | Director | February 14, 2025 | ||||
Roger B. Fradin | ||||||
* | Director | February 14, 2025 | ||||
Joanna L. Geraghty | ||||||
* | Director | February 14, 2025 | ||||
Kirk S. Hachigian | ||||||
* | Director | February 14, 2025 | ||||
Harry B. Harris, Jr. | ||||||
* | Director | February 14, 2025 | ||||
Lewis Hay III | ||||||
* | Director | February 14, 2025 | ||||
Rita S. Lane | ||||||
* | Director | February 14, 2025 | ||||
Robert B. Millard | ||||||
* | Director | February 14, 2025 | ||||
David S. Regnery | ||||||
* | Director | February 14, 2025 | ||||
Edward A. Rice, Jr. | ||||||
* | Director | February 14, 2025 | ||||
William H. Swanson | ||||||
* | Director | February 14, 2025 | ||||
Christina L. Zamarro |